These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22820807)

  • 1. Frequency and predictors for late start of antiretroviral therapy in primary care clinics, Kampala, Uganda.
    Sendagire I; Cobelens F; Kambugu A; Konde-Lule J; van der Loeff MS
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e33-9. PubMed ID: 22820807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study.
    Kesselring S; Osborne C; Bever A; Salters K; Cui Z; Chia J; Moore DM; Parashar S; Kaida A; Samji H; Duddy J; Gabler K; Howard T; Nash D; McCandless LC; Patterson TL; Corneil T; Montaner JSG; Hogg RS
    AIDS Care; 2019 Jul; 31(7):885-892. PubMed ID: 30466303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
    Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
    PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men.
    Liu Y; Ruan Y; Vermund SH; Osborn CY; Wu P; Jia Y; Shao Y; Qian HZ
    BMC Infect Dis; 2015 Dec; 15():570. PubMed ID: 26714889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
    Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
    J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
    Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study.
    Kiyingi M; Nankabirwa JI; Sekaggya-Wiltshire C; Nangendo J; Kiweewa JM; Katahoire AR; Semitala FC
    BMC Health Serv Res; 2023 Jan; 23(1):40. PubMed ID: 36647104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.
    Castelnuovo B; Musaazi J; Musomba R; Ratanshi RP; Kiragga AN
    BMC Infect Dis; 2015 Jul; 15():252. PubMed ID: 26126616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
    Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
    Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
    Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
    Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
    Sun J; Liu L; Shen J; Chen P; Lu H
    BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda.
    Muhamadi L; Tumwesigye NM; Kadobera D; Marrone G; Wabwire-Mangen F; Pariyo G; Peterson S; Ekström AM
    Pan Afr Med J; 2011; 8():40. PubMed ID: 22121448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional comparative study of risky sexual behaviours among HIV-infected persons initiated and waiting to start antiretroviral therapy in rural Rakai, Uganda.
    Nakiganda LJ; Nakigozi G; Kagaayi J; Nalugoda F; Serwadda D; Sewankambo N; Gray R; Ndyanabo A; Muwanika R; Asamoah BO
    BMJ Open; 2017 Sep; 7(9):e016954. PubMed ID: 28893749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda.
    Semeere AS; Lwanga I; Sempa J; Parikh S; Nakasujja N; Cumming R; Kambugu A; Mayanja-Kizza H
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):382-9. PubMed ID: 25171733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.